About Bee Propolis
Resin collected by honeybees; bioactives include flavonoids (chrysin, galangin, pinocembrin), CAPE (caffeic acid phenethyl ester), and artepillin C (Brazilian green type). Mechanisms: antimicrobial, antioxidant, anti-inflammatory. Several RCTs and systematic reviews support oral propolis for upper-respiratory symptom relief, oral mucositis (chemotherapy/radiation patients), recurrent aphthous stomatitis, and modest improvements in glycemic markers in T2D (Zakerkish 2019 RCT, n=94, 1000 mg/day Iranian propolis × 90 days, reduced HbA1c and fasting glucose). Topical evidence for wound healing and herpes labialis is stronger than oral systemic claims. Allergy risk: propolis is a known contact allergen, especially in beekeepers and those allergic to bee products.
What Bee Propolis supports
- Moderate evidence as an adjunct for oral mucositis and aphthous ulcers
- Some RCT support for shorter upper-respiratory infection duration
- Modest glycemic improvements in type 2 diabetes in small RCTs at 1000 mg/day
How much Bee Propolis to take
The RDA prevents deficiency. The effective range is what clinical trials used to actually move the outcome.
Effective
500–1000
mg
Daily oral dose range used in immune, oral-health, and metabolic RCTs. Zakerkish 2019 T2D trial used 1000 mg/day; oral-mucositis adjuncts use 400–500 mg+; URI trials cluster at 500 mg+. Composition varies dramatically by region (Brazilian green propolis is artepillin-C-rich; European poplar-type is CAPE-rich), so dose-response is heterogeneous.
Clinical evidence
Moderate clinical evidence. Multiple small-to-medium RCTs across oral health, URI (Arentz 2021 rapid systematic review, PMID 34611512), and T2D (Zakerkish 2019, PMID 31086222, n=94). Composition varies by source; quality of evidence is moderate, not high.
Reference